No signs of dose escalations of potent opioids prescribed after tibial shaft fractures: a study of Swedish National Registries by Zewar Al Dabbagh et al.
Al Dabbagh et al. BMC Anesthesiology 2014, 14:4
http://www.biomedcentral.com/1471-2253/14/4RESEARCH ARTICLE Open AccessNo signs of dose escalations of potent opioids
prescribed after tibial shaft fractures: a study of
Swedish National Registries
Zewar Al Dabbagh1*, Karl-Åke Jansson1, Carl-Olav Stiller2, Scott Montgomery3,4,5 and Rüdiger J Weiss1Abstract
Background: The pattern of opioid use after skeletal trauma is a neglected topic in pain medicine. The purpose of
this study was to analyse the long-term prescriptions of potent opioids among patients with tibial shaft fractures.
Methods: Data were extracted from the Swedish National Hospital Discharge Register, the National Pharmacy
Register, and the Total Population Register, and analysed accordingly. The study period was 2005–2008.
Results: We identified 2,571 patients with isolated tibial shaft fractures. Of these, 639 (25%) collected a prescription
for opioids after the fracture. The median follow-up time was 17 (interquartile range [IQR] 7–27) months. Most
patients with opioid prescriptions after fracture were male (61%) and the median age was 45 (16–97) years. The
leading mechanism of injury was fall on the same level (41%). At 6 and 12 months after fracture, 21% (95% CI 17–24)
and 14% (11–17) were still being treated with opioids. Multiple Cox regression-analysis (adjusted for age, sex, type
of treatment, and mechanism of injury) revealed that older patients (age >50 years) were more likely to end opioid
prescriptions (Hazard ratio 1.5 [95% CI 1.3-1.9]). During follow-up, the frequency of patients on moderate and high
doses declined. Comparison of the daily morphine equivalent dose among individuals who both had prescriptions
during the first 3 months and the 6th month indicated that the majority of these patients (11/14) did not have
dose escalations.
Conclusions: We did not see any signs in registry-data of major dose escalations over time in patients on potent
opioids after tibial shaft fractures.
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Previous studies on consumption of opioids in patients
with non-cancer pain were either non population-based
[1,2], limited to a specific population, such as workers
with low back injuries [3-5], or had only a short follow-up
[6]. Moreover, studies dealing with concerns of abuse, side
effects, and efficacy of long-term opioid therapy in these
conditions have not been conclusive [7-9].
There is a lack of studies on the pattern of opioid use
after skeletal fractures. Most of the reports in the literature
are concerned with chronic back pain or other non-cancer* Correspondence: zewar.al-dabbagh@karolinska.se
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article, unless otherwise stated.pain conditions, but not with skeletal trauma patients
[2,10,11]. The design and results of these studies illustrate
the need for more selected patient groups with specific
end-point data such as skeletal injuries.
Fractures of the tibial shaft are among the most com-
mon of serious skeletal injuries [12]. They are slow to
heal and frequently cause permanent sequelae [13]. We
analysed the long-term pattern of opioid consumption in
patients with tibial shaft fractures. We aimed to study if
potential risk factors such as age, sex, type of treatment,
and mechanisms of injury would predict a prolonged
opioid therapy. Moreover, we wanted to assess the poten-
tial risk of dose escalations in prescribed opioids in these
patients.ntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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Sweden has a unique personal identification number for
all residents, which allows linkage between healthcare and
other information from different registers for research.
Data on all patients with tibial shaft fractures were ob-
tained from the Swedish National Hospital Discharge
Register (SNHDR). The Register records diagnoses and
designated treatment codes according to the International
Classification of Diseases (ICD), covering at least 98% of
all hospital admissions in Sweden. A matched control
group without tibial fractures was extracted from the Total
Population Register. Each patient in the fracture group
was matched with five individuals by age, sex, and resi-
dential area. None in the control group had been admit-
ted to a hospital for a tibial fracture during the study
period. Data on death or emigration for both groups
were retrieved by Statistics Sweden from the Total
Population Register.
Since July 1, 2005, all prescriptions filled at pharmacies
in Sweden are stored in the National Pharmacy Register
[14]. This does not include over-the-counter sales, which
include some analgesics such as paracetamol and some
of the non-steroidal anti-inflammatory drugs. However,
opioid analgesics can only be obtained in pharmacies
with prescription and are thereby included in the Register.
We identified all admissions in the SNHDR with ICD
diagnostic codes for tibial shaft fractures (S822, S8220,
and S8221). Relevant surgical intervention codes were
analysed accordingly (NGJ29-NGJ99). Mechanisms of in-
jury were studied using ICD E-codes (external codes) and
grouped into 6 categories: fall on the same level, fall from
height, unspecified fall, transport accident, miscellaneous,
and unreported cause. The study period was July 1, 2005
to December 31, 2008.
All opioid analgesics prescribed to the patients in the
study and control group were extracted from the National
Pharmacy Register. These data include the following:
name of the drug, date of filling the prescription, drug
strength, number of pills, and dosage. The morphine
equivalent dose (MED) for each opioid prescription in
milligrams (mg) was calculated by multiplying the num-
ber of pills prescribed by the drug strength. These doses
were then converted to MED using available equianal-
gesic conversions [15]. The median MED per day was
calculated for each month. The MED was categorized as
beeing low (< 20 mg), moderate (20–180 mg), or high
(>180 mg) [16,17]. We analysed potent opioids (oxycodone,
morphine, and fentanyl), whereas less potent opioids
(dextropropoxyphene, codeine, and tramadol) were not
included [18]. We did not want to be biased by patients
with associated fractures, therefore we exluded all pa-
tients with other fractures than tibial shaft fractures.
Moreover, we excluded patients who had potent opioids
before the index hospitalisation, as we wanted to studynew opioid use after fracture. The study was approved by
the regional ethical review board located at the Karolinska
Institutet (2009/837-31/3 and 2010/0125-32).Statistical analysis
We used descriptive statistics to define the median
values with interquartile ranges (IQR). Kaplan-Meier
analysis calculated the cumulative opioid consumption
with 95% confidence intervals (CI). The opioid therapy
was considered to be ceased when no new prescription
was found during 3 consecutive months of follow-up (after
3 months a new opioid prescription has to be issued).
We used the Cox multiple-regression model to study
risk factors for a prolonged opioid consumption after
sustaining the fracture. Results were expressed as hazard
ratios (HR) with corresponding 95% CI. If the HR is >1,
the patients are more likely to end getting opioids com-
pared with patients in the reference group. In the simple
Cox model, we studied the following risk factors: age,
sex, method of treatment (surgical or non-surgical) as
well as mechanism of injury. All variables were later
adjusted for in a multiple Cox model.
Logistic regression analysis compared the group of
patients using opioids after the fracture with those who
never had opioid prescriptions during follow-up. The
dependent variable in the model was opioid use (yes/no)
and the covariates were age, sex, type of treatment, and
mechanism of injury. The level of significance was set at
P < 0.05. All statistics were performed using the PASW
statistics package version 18 (SPSS inc., Chicago, Illinois,
USA).Results
Study population
We identified 3,732 patients (>= 16 years of age) who were
hospitalized with tibial shaft fractures. We excluded all pa-
tients with associated fractures and patients using opioids
before the index hospitalization. This left us with a final
sample size of 2,571 patients. Of those, 639 (25%) had pre-
scriptions of opioids after the fracture (new opioid use)
(Figure 1). The corresponding age- and sex-matched con-
trol cohort consisted of 12,855 individuals (median age 46
[16–101] years, 62% men). Filling a prescription on opioid
analgesics in the controls was seen in 353 (3%) cases dur-
ing the same observation period.
Baseline data of the final study cohort with new opi-
oid use after isolated tibial shaft fractures (n = 639) is
shown in Table 1. The median age was 45 (16–97) years
and most of the patients were males (61%). The type of
fracture was most often a closed fracture (78%) and surgi-
cal treatment was chosen in the majority of the cases
(81%). The mechanism of injury was fall on the same level
in 41% of the cases, followed by transport accidents








Patients with tibial fracture
n=3,732
Opioid use after tibial
fracture
(new opioid use)?
Combination of tibial and other 
fractures n=1,073 (29%)
Figure 1 Cohort eligibility and final sample size.
Table 1 Baseline characteristics
Total number of patients 639
Age












Fall on the same level 262 (41%)
Fall from height 66 (10%)
Fall unspecified 53 (8%)
Transport accident 133 (21%)
Miscellaneous 115 (18%)
Missing 10 (2%)
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17 (IQR 7–27) months.Opioid prescriptions
Kaplan-Meier analysis revealed that 6, 12, and 18 months
after sustaining the tibial fracture, 21% (95% CI 17–24),
14% (11–17), and 11% (8–13) still required opioid pre-
scriptions, respectively (Figure 2). The median daily MED
was 21 (IQR 8–32) mg within the first month after the
fractures for those patients who were started on opioids
(Figure 3).
Figure 4 shows the distribution of patients on various
doses during different exposure windows. The first pre-
scription of opioids was filled during the first month after
fracture by the majority of the patients (86%) (Figure 4).
During the study period, the proportion of patients using
moderate and high doses decreased and the proportion
of patients who stopped taking opioid drugs increased
(Figure 4).
Comparison of the daily MED among individuals who
both had prescriptions during the first 3 months and the
6th month indicated that the majority of these patients
(11/14) did not have dose escalations (an increase by more
than 30% of the original dose).
The simple (unadjusted) Cox regression-analysis showed
that older patients (> 50 years) (HR 1.7), women (HR 1.3),
and non-surgical treatment (HR 1.4) made it less likely
to continue opioid analgesic use. After adjustment for
covariates in the multiple Cox analysis, older age was
Number of patients
Time after fracture (month)
Opioid prescription (%)
639 103 56 31 15







Figure 2 Kaplan-Meier-analysis with 95% confidence intervals
of the last opioid prescription of patients with tibial fractures.
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Figure 3 The median (interquartile range) morphine equivalent
dose (MED) in milligram (mg) per day prescribed to patients
with tibial fractures in different time periods after fracture.







Time (month) since fracture
0
Figure 4 The distribution of opioid prescriptions in 639 patients
in different time intervalls after tibial fracture (low dose, < 20 mg
MED per day; moderate, 20 < 180 mg; high > 180 mg; MED =
morphine equivalent dose).
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opioid use sooner (HR 1.5) (Table 2).
Patients with isolated tibial fractures who received opi-
oids after fracture (n = 639) were compared with the pa-
tients who did not get opioid prescriptions (n = 1,932).
There was no difference concerning age, sex, and mechan-
ism of injury between the 2 groups (data not included).
However, patients receiving opioids during follow-up were
more likely to have undergone surgery for the fracture
(odds ratio 2.3, 95% CI 1.7-2.6, p < 0.001).
Discussion
There has been a continuous increase of opioid use for
pain treatment among patients with non-cancer pain
conditions during the past decade [19]. We studied the
long-term opioid prescriptions after tibial shaft fractures
in a national Swedish study. 25% of the patients filled a
prescription for opioid analgesics at some point after the
fracture. However, the doses prescribed were rather low
and we did not see any evidence of a major dose escala-
tions over time.
We excluded all patients with potent opioid prescriptions
prior to the fracture, as we wanted to study the occurrence
of new opioid prescriptions. Moreover, we excluded pa-
tients with other fracture diagnoses as we wanted study
a rather homogenous fracture cohort. We are aware
that the included patients may have obtained opioids
during follow-up due to other reasons than the skeletal
injury such as back pain, extremity pain, and abdominal
pain. Therefore, an age- and sex-matched control co-
hort without fracture was included for comparison. In a
cross-sectional survey from 2010 based on a nationwide
register in Denmark, a high overall prevalence of opioid
consumption (4.5%) was found in the general population.
Table 2 639 patients with new opioid use after tibial fracture (Cox regression analysis)
Simple Cox regressiona Multiple Cox regressionb
Covariate No. of patients HR 95% CI p-value HR 95% CI p-value
Age < 50 years 364 Reference Reference
> 50 years 275 1.7 1.4-2.0 0.001 1.5 1.3-1.9 0.001
Sex Male 389 Reference Reference
Female 250 1.3 1.1-1.6 0.002 1.1 0.9-1.4 0.2
Type of fracture Closed 499 Reference Reference
Open 103 0.9 0.7-1.2 0.4 0.9 0.7-1.1 0.3
Unspecified 37 0.6 0.4-0.8 0.004 0.6 0.4-0.9 0.022
Treatment Surgical 520 Reference Reference
Non-surgical 119 1.4 1.1-1.8 0.004 1.1 0.9-1.4 0.6
Mechanism of injury Fall on the same level 262 Reference Reference
Fall from height 66 0.9 0.6-1.2 0.4 0.8 0.6-1.1 0.2
Fall unspecified 53 0.9 0.6-1.2 0.5 0.9 0.6-1.2 0.5
Transport accident 133 1.1 0.9-1.4 0.4 0.9 0.7-1.2 0.5
Miscellaneous 115 1.2 1.0-1.6 0.1 1.1 0.8-1.4 0.6
Missing 10 1.0 0.6-2.0 0.9 1.0 0.5-1.8 0.9
HR = hazard ratio, CI = confidence interval, acrude, badjusted for age, sex, type of fracture, treatment, and mechanism of injury; if the HR is >1, the patients are
more likely to end opioid intake compared with the reference group.
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These findings are in accordance with our findings of an
opioid use of 3% in the control cohort without tibial
fracture.
We did not detect any indication of major dose escal-
ation in our cohort during the follow-up period. The
median daily MED was between 7 and 21 mg during
month 1 and 12 after fracture. Furthermore, as shown in
Figure 4, the median MED for patients taking opioids
was predominantly moderate to low in the beginning.
During follow-up, the frequency of patients on moderate
and high doses reduced. This is consistent with other
data concerning non-trauma related pain conditions. In
a meta-analysis of efficacy and safety of long-term opioid
therapy for chronic non-cancer pain, many patients dis-
continued the therapy and very few patients showed
signs of opioid addiction or abuse [21].
Our finding of a higher risk for continued use of opi-
oids in younger patients (< 50 years) may be explained
by a more extensive injuries often sustained during
transport accidents in comparison with falls on the same
level which is more often seen in elderly people. Further-
more, this finding for the older patient group may be
reassuring, recently published reports raised increasing
concerns on the safety of opioid analgesics in elderly
people [22-24].
The shortcomings of our study include the following:
opioids prescribed to patients is not always equivalent to
requirement or consumption of opioids. The incidence
figures in this study may present and over- or underesti-
mation of actual opioid use. An overestimation of theuse of potent opioid analgesics is due to the fact that not
all prescribed drugs are consumed. Thus the actual
number of consumed doses is probably lower than 100
percent. In contrast, we did not include less potent
opioids such as codein which converts to morphine in
the liver, resulting in an underestimation. Moreover, we
did not analyse other analgesics such as COX-inhibitors
which may augment the analgesic effect of opioids redu-
cing the quantity of the consumed opioid required. A
further limitation of the study is: we do not know
anything about the efficacy of the analgesic treatment.
Lack of analgesic effect and/or side effects of opioids are
major reasons why opioid therapy is stopped [25]. Patients
may also, after some time, be prescribed less potent opi-
oids by their general practitioners, who may be reluctant
to provide potent opioids for non-cancer pain. This is a
register study, therefore we do not know the specific
reason why the patients discontinued the use of opioid
medication. For example, one reason for discontinuing
opioid treatment for elderly patients could be due to a
higher incidence of adverse events. We also do not
know if the excluded patients, who were already taking
opioids prior to their tibial fracture, had an increase in
their prescribed opioids following the fracture.
Our study is based on well validated government con-
trolled national registries, including all hospitalized patients
and opioid prescriptions in Sweden. We only studied the
use of strong opioids in order to get a more homogenous
patient group and to guarantee that the patients’ con-
sumption is registered in order to obtain accurate statistics
regarding drug escalation problems.
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We did not see any signs from registry-data of major
dose escalations over time among patients who received
prescriptions for potent opioid analgesics after tibial shaft
fractures.
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